Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. - Wikidata - awgldk - TriplyDB

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

http://www.wikidata.org/entity/Q43722419

about

Neural network analysis in pharmacogenetics of mood disorders From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response Pharmacogenetics of antidepressant response.Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Pharmacogenetics of antidepressants The promise and reality of pharmacogenetics in psychiatry Pharmacogenomic strategy for individualizing antidepressant therapy.Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.Psychiatric pharmacogenomic testing in clinical practice PharmGED: Pharmacogenetic Effect Database.Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.Pharmacogenetics and bipolar disorder.The pharmacogenomics of selective serotonin reuptake inhibitors.Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and response.Genetics and psychopharmacology: prospects for individualized treatment.Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.Pharmacogenomics and antidepressant drugs.Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.Candidate genes for antidepressant response to selective serotonin reuptake inhibitors Routine pharmacogenetic testing in clinical practice: dream or reality?The serotonin transporter gene and effectiveness of SSRIs.Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.Pharmacogenomics with antidepressants in the STAR*D study.Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety.Mechanisms of antidepressant resistance Pharmacogenetics of antidepressant response: an update Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions.Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Pharmacogenomics of bipolar disorder.Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.

P2860

Q24792166-31CFC070-CE1D-433A-AE42-40470F1FC16C Q27015830-A35C1E6C-0477-4CD8-BB02-AC3FAFA300A2 Q28216643-E368CAB9-D6CC-43C8-AE98-F1EFCE00234A Q28252209-59BEE412-4043-4C36-A5C8-8B7635EE493F Q34155796-F846ED76-A4FE-4DAD-8096-490A4858E68E Q34348095-3FC71B32-32C7-47E7-9A48-19A9112DE82F Q34424865-D3F3D5B7-8BD7-4B0E-97AE-F11A29930E84 Q34473840-F9FECA49-1E20-4C7E-917F-2D18B491EA38 Q34871885-09038BCA-7BB5-4EC3-A64F-C65999D65635 Q35026088-801FFC63-1E31-4736-9CF3-243A7BF44941 Q35226451-464FEB88-D322-41C0-BAC3-3949CB18E62A Q35237038-CC613802-C8B3-4A36-B841-185F095981F3 Q35237042-9DE69D51-FDAE-4CDC-9EDD-8CF9868C3738 Q35237152-0167AD98-990F-43CB-8E3C-911F56BF3EB2 Q35567962-14ACEDE6-F2F6-4871-B697-9BA7632E8F28 Q35705858-3A43A184-E3F1-4E2D-86F4-75E71066B3AB Q35744024-4F9E4BB6-7E03-4384-8C52-0A68BCD37238 Q35757723-A6BEDA16-A9AF-4F5A-B5C8-5678EF8F0053 Q35814369-E253B2EA-E995-43BD-861E-B1395A6EC96D Q36206096-3A50E570-DCE8-41FA-B9B5-A9D90DB04643 Q36254513-1CA6D9EE-3457-4841-AFEF-D0711E1F4FE7 Q36438205-054B1B79-8381-41E2-90F7-44EAD651DF08 Q36491587-B261DD2B-6AE5-4F88-9A2D-1A0A568D66AD Q36677271-9A4DA3D7-10C2-4F8E-A82F-DC35B77A1B40 Q36718053-7BD098A1-D928-4396-AE85-0496D746D738 Q36989859-757E52AE-2FC1-4437-A6DE-64D927C1413D Q37035245-318AE112-6F03-4940-A2A8-7EEDEAAA7925 Q37037060-D75E8BF6-3993-4AFD-9C11-AC8D8C554EFD Q37205961-4CF1A260-2B9F-48E0-9FD3-B9476168A9FC Q37329171-BA57F8FF-2994-4E87-B422-017C49C59ECF Q37334088-88EB31C5-3182-4011-8252-F90C66E50C6B Q37464458-C0EA33E9-89BD-4ADE-9629-E96457A3863E Q37532496-719F3D22-40B1-4CB1-A300-0491B20DF09C Q37791156-19291CAE-B492-401C-9802-51F458F20545 Q37989490-A6051063-44FC-4556-9628-2F8B994840FE Q38097534-AB9E3D08-5F3D-4A61-B441-F735FBBEEF10 Q38121519-8A475C6D-D994-4F70-B722-515558AAD4BA Q38983579-7D9974E3-5E76-4DAC-92C9-2C85E51DD318 Q40370839-E4773ED4-3C43-4C60-8BE2-499110382905 Q44245157-5F6C4599-15F1-4BD1-B077-47ED5D5BD6CB

P2860

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

http://www.wikidata.org/entity/Q43722419

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Influence of tryptophan hydrox ...... amine antidepressant activity.

@en

Influence of tryptophan hydrox ...... amine antidepressant activity.

@nl

type

label

Influence of tryptophan hydrox ...... amine antidepressant activity.

@en

Influence of tryptophan hydrox ...... amine antidepressant activity.

@nl

prefLabel

Influence of tryptophan hydrox ...... amine antidepressant activity.

@en

Influence of tryptophan hydrox ...... amine antidepressant activity.

@nl

P1433

Q43722419-15E4B4D2-0FF6-47B1-B200-0653A5CF8E6D

P1476

Q43722419-D23E4FB6-CAFA-41F9-B44C-245FC8040FC5

P2093

Q43722419-077FC154-7685-4488-B66C-D3820FDE0952

Q43722419-976FC4E3-F48E-41FD-8280-EFD859DF2C52

Q43722419-C42B770B-CB2C-4E12-A079-2217EB886339

Q43722419-F0D45102-1856-46AD-8A71-14768FB1B0EA

Q43722419-F79983F6-665C-4596-A968-FC03BEC4CEE0

P2860

Q43722419-09D81092-4763-4BEC-BB1D-34515650F795

Q43722419-0A877F18-4FE8-4FAC-8726-7CD710616985

Q43722419-1167B1F8-CF1B-4C2F-94F7-A830FE3DFFD5

Q43722419-1AE3488A-B26C-4504-AA68-638EE1E0D39A

Q43722419-223555A7-F97D-4971-B349-208614C7413E

Q43722419-28B240C1-F3A9-41E8-AC41-4A5430210945

Q43722419-30ABB5FB-8356-4805-AD0A-9B4C2CE54B94

Q43722419-32F01B5D-53CB-495B-B8DB-D8A3F3CD0F70

Q43722419-34C71C95-7201-4C87-8CFE-5F9DD30C2C38

Q43722419-36A51E4A-946E-4B99-88CB-3B6F3D6ABF97

P2888

Q43722419-F082ED4F-E0BD-4633-B755-EA2B90240FBD

P304

Q43722419-13819891-54F9-429D-B578-EF3B59D5BC8E

P31

Q43722419-D9D2D576-65E4-4291-B154-8F00E7A4A190

P356

Q43722419-114D82B4-F2E4-4E9B-9D9A-FD46E0FDE13C

P407

Q43722419-EE53C3EC-1EE6-4994-9713-B3C54701DBE5

P433

Q43722419-F34E497E-DAB7-4149-ABF3-798BA1E5C7C9

P478

Q43722419-4B15381A-DE07-46E6-98E6-02AFEDB2155B

P50

Q43722419-1AE6364E-EB28-4002-BB3E-8E9284D0603B

P577

Q43722419-74BCEE56-3F93-475A-BCFE-783879D35161

P5875

Q43722419-E8870DD0-80F3-485F-8172-68FEDF8B2E98

P698

Q43722419-DC979054-59A6-4282-8EA1-634D32A9665C

P921

Q43722419-745c97df-1efb-46a4-8ca7-217335768fc2

P356

P1433

Molecular Psychiatry

P1476

Influence of tryptophan hydrox ...... xamine antidepressant activity

@en

P2093

Cusin C

http://www.w3.org/2001/XMLSchema#string

Lilli R

http://www.w3.org/2001/XMLSchema#string

Rossini D

http://www.w3.org/2001/XMLSchema#string

Smeraldi E

http://www.w3.org/2001/XMLSchema#string

Zanardi R

http://www.w3.org/2001/XMLSchema#string

P2860

Complete coding sequence of human tryptophan hydroxylase

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

Identification of four variants in the tryptophan hydroxylase promoter and association to behavior

Development of a rating scale for primary depressive illness

Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization.

Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7.

Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients.

L-tryptophan in neuropsychiatric disorders: a review.

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

P2888

P304

586-592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MP.4000876

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Alessandro Serretti

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11820389

http://www.w3.org/2001/XMLSchema#string

P698

11526473

http://www.w3.org/2001/XMLSchema#string

P921